![shutterstock_172796345](https://www.nationalelfservice.net/cms/wp-content/uploads/2014/04/shutterstock_172796345-150x150.jpg)
Schizophrenia is a crippling condition that often (in about 20-30% of patients) shows an inadequate response to first-line antipsychotic drugs. Because it is associated with significant, often devastating reductions in quality of life, the management of refractory cases of schizophrenia represents a major challenge to psychiatry. As pharmacotherapy is the treatment of choice, stringent guidelines [read the full story…]